Home/Filings/4/0001280776-19-000017
4//SEC Filing

Ashley Robert A. 4

Accession 0001280776-19-000017

CIK 0001280776other

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 9:49 PM ET

Size

20.4 KB

Accession

0001280776-19-000017

Insider Transaction Report

Form 4
Period: 2019-01-11
Ashley Robert A.
See Remarks
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-01-1123,3440 total
    Exercise: $0.43From: 2016-04-25Exp: 2022-04-24Common Stock (23,344 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-01-11241,6700 total
    Exercise: $8.00From: 2016-09-13Exp: 2022-09-25Common Stock (241,670 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-01-1175,0000 total
    Exercise: $3.20Exp: 2027-06-09Common Stock (75,000 underlying)
  • Award

    Restricted Stock Units

    2019-01-11+816,634816,634 total
    Common Stock (816,634 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-01-1175,0000 total
    Exercise: $8.28Exp: 2026-05-12Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-01-1175,0000 total
    Exercise: $5.00Exp: 2028-06-08Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2019-01-1193,3770 total
    Exercise: $0.43From: 2016-02-08Exp: 2022-03-31Common Stock (93,377 underlying)
Footnotes (6)
  • [F1]The option was cancelled by mutual agreement of the reporting person and Vital Therapies, Inc. The reporting person received a restricted stock unit award as reported in this Form 4 as consideration for this cancellation.
  • [F2]Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the "Plan")), one forty-eighth (1/48th) of the shares subject to the option vested and became exercisable one month after the vesting commencement date of April 16, 2016, and an additional one forty-eighth (1/48th) of the shares vest and become exercisable at the end of each monthly period thereafter. One hundred percent (100%) of the unvested portion of the option, if any, shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan).
  • [F3]Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the "Plan")), one forty-eighth (1/48th) of the shares subject to the option vested and became exercisable one month after the vesting commencement date of June 10, 2017, and an additional one forty-eighth (1/48th) of the shares vest and become exercisable at the end of each monthly period thereafter. One hundred percent (100%) of the unvested portion of the option, if any, shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan).
  • [F4]Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan (the "Plan")), one forty-eighth (1/48th) of the shares subject to the option vested and became exercisable one month after the vesting commencement date of June 9, 2018, and an additional one forty-eighth (1/48th) of the shares vest and become exercisable at the end of each monthly period thereafter. One hundred percent (100%) of the unvested portion of the option, if any, shall vest in the event of a termination without cause following a Change in Control (as defined in the Plan).
  • [F5]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vital Therapies, Inc. Common Stock.
  • [F6]Subject to the reporting person continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), twenty five percent (25%) of the RSUs vest annually after the vesting commencement date of January 11, 2019. One hundred percent (100%) of the unvested portion of the RSUs, if any, shall vest in the event of a Termination without Cause or Resignation for Good Reason (each as defined in the reporting person's Change of Control and Severance Agreement).

Issuer

VITAL THERAPIES INC

CIK 0001280776

Entity typeother

Related Parties

1
  • filerCIK 0001591017

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 9:49 PM ET
Size
20.4 KB